Neuralstem Reports Third Quarter 2015 Financial Results Nov 9, 2015 09:03AM
Neuralstem Investigator Provides Phase II Update on ALS Cell Therapy at American Neurological Association Annual Meeting Sep 29, 2015 08:01AM
Neuralstem Investigator to Provide Update on ALS and Alzheimer's at American Neurological Association Annual Meeting Sep 24, 2015 09:01AM
Neuralstem Reports Second Quarter 2015 Financial Results Aug 10, 2015 08:05AM
US District Court Rules In Favor Of Neuralstem In Patent Infringement Case Jul 23, 2015 07:45AM

Jun 29, 2015 09:22AM Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market
Jun 26, 2015 07:32AM Preclinical Data On Neuralstem's Genetically Modified HK532-IGF-1 Stem Cells In Alzheimer's Disease Presented At International Society For Stem Cell Research Annual Meeting
May 8, 2015 07:30AM Neuralstem Reports First Quarter 2015 Financial Results And Provides Business and Clinical Update
May 6, 2015 07:31AM Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer
Mar 16, 2015 07:30AM Neuralstem Reports Fiscal 2014 Fourth Quarter Financial And Year-End Business Results
Mar 12, 2015 06:50AM Neuralstem Announces Topline Results Of Phase II ALS Trial